Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2024.07.29

Sai Life Sciences inducts 96 trainees across campuses in India

"I just got my first pair of safety shoes and I'm thrilled! Exploring the facility for the first time is such a joy!" - Spurthi R, Trainee, Medicinal Chemistry, Shamirpet.

Ushering in a season of new beginnings, we welcomed 96 trainees across our campuses in India. These young individuals have been selected from eight colleges across Maharashtra, Karnataka, Telangana, and Tamil Nadu, in India, and joined our integrated R&D campus in Shamirpet and our flagship API manufacturing unit in Bidar.

The trainees have been placed in departments such as Production, Process Engineering, HSE, QA/QC, Engineering, Stores, Medicinal Chemistry, Biology and Pre-Sales, among others. This diverse placement ensures they gain comprehensive insights into our operations while actively contributing to our ongoing projects.

At Sai Life Sciences, our trainee programs are designed to onboard fresh talent and provide mentorship and hands-on experience, enabling them to gain first-hand knowledge of the operations in the CRO-CDMO space and setting the stage for their professional growth.

The influx of new talent enriches our workplace culture, injecting new ideas and energy into every facet of our operations. We believe in fostering an environment where collaboration, learning, and personal growth thrive, ensuring our trainees develop both professionally and personally.

Share article

More News

2024.10.28

Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) for its R&D (Unit II, Hyderabad), and Manufacturing (Unit IV, Bidar) sites in India. The General Good Manufacturing Practices (GMP) audit was conducted at the […]
Read more

2024.10.07

Sai Life Sciences releases Sustainability Report 2024

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its Sustainability Report for 2023-2024. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, this fifth edition of the Sustainability Report is based on the theme, ‘Synergising Sustainability, Performance and Growth.’ The full report can be read here. Making […]
Read more

2024.08.09

Sai Life Sciences elevates Compound Management process with in-house software application, CORAL

Compound management is a vital function in pharmaceutical research. A streamlined environment can bring significant value to the process in the form of productivity and efficiency. Recognizing the importance of this function, we have made our Compound Management suite for Discovery services smarter with the introduction of an in-house software application, Compound Organization and Registration […]
Read more

2024.02.08

Sai Life Sciences releases its Sustainability Report 2023

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability […]
Read more

2024.02.01

Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations

To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), has expanded its DMPK capabilities. The expansion comprises the addition of 25,000 sq. ft. of state-of-the-art labs equipped with cutting-edge instrumentation enabling high-end automation. Complementing the expansion has been […]
Read more